TNFAIP6 and bronchopulmonary dysplasia: Bryan et al.87and Chaubey et al.88reported a decrease in lung apoptosis and a major improvement in alveolar disruption in BPD models treated with MSCs where high levels of TSG‐6 were present in the lung tissues, supporting the theory concerning the role of TSG‐6.